dc.contributor.author | McKellar, Quintin | |
dc.date.accessioned | 2014-06-04T10:30:28Z | |
dc.date.available | 2014-06-04T10:30:28Z | |
dc.date.issued | 1993-08 | |
dc.identifier.citation | McKellar , Q 1993 , ' Pharmacokinetics and clinical effects in dogs of a sustained-release formulation of theophylline ' , Veterinary record , vol. 133 , no. 6 , pp. 133-136 . https://doi.org/10.1136/vr.133.6.133 | |
dc.identifier.issn | 0042-4900 | |
dc.identifier.uri | http://hdl.handle.net/2299/13611 | |
dc.description.abstract | Theophylline was administered orally in a sustained-release preparation at a dose rate of 20 mg/kg bodyweight to six beagle dogs. A mean (+/- se) maximum plasma concentration of 12.2 +/- 0.65 micrograms/ml was obtained 5.17 +/- 0.70 hours after administration and it was calculated to have a mean residence time of 9.09 hours. When given at 40 mg/kg bodyweight twice daily for five days the theophylline preparation was well tolerated, but, the dogs developed a marked tachycardia and hyperpnoea which were attributed to the high plasma concentrations (> 30 micrograms/ml) reached during this dosage regimen. | en |
dc.format.extent | 4 | |
dc.language.iso | eng | |
dc.relation.ispartof | Veterinary record | |
dc.title | Pharmacokinetics and clinical effects in dogs of a sustained-release formulation of theophylline | en |
dc.contributor.institution | Office of the Vice-Chancellor | |
dc.contributor.institution | Veterinary Science | |
dc.description.status | Peer reviewed | |
rioxxterms.versionofrecord | 10.1136/vr.133.6.133 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |